-- Sigma Healthcare(ASX:SIG)周二宣布与Greenlight Healthcare签署谅解备忘录,根据该备忘录,Chemist Warehouse品牌将进入英国市场。 该公司在一份声明中表示,将收购这家员工持股的药房集团旗下多家门店75%的股份,Greenlight将继续持有剩余的25%股份。 Sigma将获得Chemist Warehouse品牌和知识产权的授权,并提供零售支持;Greenlight将提供配药和专业服务以及后台支持。 合资企业的第一阶段将专注于品牌重塑,并首先开发至多五家门店,首家门店将位于伦敦市东北部的霍克斯顿街。如果第一阶段取得成功,第二阶段可能会开发更多门店。双方计划确定现有的Greenlight药房,并在适当情况下将其改造或搬迁至Chemist Warehouse门店。 Sigma Healthcare的股票在周二的近期交易中上涨了近4%。
Related Articles
Mahindra Holidays & Resorts India Names CFO
Mahindra Holidays & Resorts India (NSE:MHRIL, BOM:533088) has appointed Rajiv Vimal as the chief financial officer and key managerial personnel of the company with effect from July 1, according to a Tuesday filing to the Indian stock exchanges.He takes over from Vimal Agarwal, who will resign as chief financial officer and key managerial personnel of the company, with effect from June 30, to transition to a new role within the Mahindra Group.The company's shares were down nearly 1% in recent trade.
Jefferies Adjusts Cholamandalam Investment and Finance's Price Target to INR1,960 From INR2,040, Keeps at Buy
Cholamandalam Investment and Finance (NSE:CHOLAFIN, BOM:511243) has an average rating of overweight and mean price target of 1,811.95 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Jefferies Adjusts Hyundai Motor India's Price Target to INR1,600 from INR1,900, Keeps at Underperform
Hyundai Motor India (NSE:HYUNDAI, BOM:544274) has an average rating of overweight and mean price target of 2,247.41 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)